Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul class="summary-list"><li>Jennifer Davis was the first person to get a breast-cancer vaccine. It's showing remarkable results.</li><li>The shot she received is among several of breast-cancer vaccines in early-stage trials.</li></ul>This as-told-to essay is based on a conversation with Jennifer Davis. It has been edited for length and clarity.My breast cancer was in remission, but I was in a constant state of worry that it would return. I had <a href="https://www.insider.com/guides/health/conditions-symptoms/triple-negative-breast-cancer">triple-negative breast cancer</a>, or TNBC, one of the most deadly forms of the disease with a high rate of recurrence.The one and only time I'd Googled it — soon after my diagnosis in September 2018 — I was shocked to read that this kind of cancer reoccurred around 60% of the time. Once you have a recurrence with triple negative, it's usually <a href="https://www.insider.com/guides/health/conditions-symptoms/metastatic-breast-cancer">metastatic</a> breast cancer, meaning it's no longer isolated to one area of your body. There is no cure.<h2>The breast-cancer vaccine had not been tested on humans before</h2>Every day, I lived with fear. If I got a headache, I thought it was a brain tumor. If I had an ache in my arm because I'd slept on it wrong, I thought I had bone cancer. My whole family worried for me, too.They'd watched me undergo <a href="https://www.insider.com/jeff-bridges-almost-died-covid-chemotherapy-2022-5">chemotherapy</a> followed by a double <a href="https://www.insider.com/former-nbc-news-anchor-jenna-wolfe-undergoes-elective-mastectomy-update-2023-4">mastectomy</a> and radiation. But at that point, I was in remission.In June 2021, I had my three-month checkup at the doctor's office. The nurse practitioner told me about the trial of a breast-cancer vaccine, and she said it was close to being ready.The vaccine had been in development for the past 20 years, but it had never been tested on humans. <a href="https://www.anixa.com/" target="_blank" rel="noopener">Anixa Biosciences</a>, the company behind the shot, was looking for volunteers for the first phase of the human trial.<div type="image" title="Jennifer Davis in a clinic receiving her first dose of a promising breast cancer vaccine under trial." height="2268" width="3023" msid="100702746" hostid="261" sizebytes="291276"></div>I didn't hesitate. I thought: "What a gift for me that this could possibly work. I get to live to see my kids get married and have children themselves." I hoped that one day, people would never have to worry about breast cancer — especially triple negative — ever again.I asked the inventor of the vaccine if he'd seen any terrible reaction in the mice who'd received it so far. "Did any of them die?" I said. He said no.I asked how many of these animals had experienced a recurrence of TNBC. "Zero," the doctor, who was based at the <a href="https://my.clevelandclinic.org/" target="_blank" rel="noopener">Cleveland Clinic</a> in Ohio, said. <h2>The medical staff applauded when I received the vaccine</h2>The vaccine is designed to train the immune system to destroy cells that are producing a protein called alpha-lactalbumin. The protein is present only when a woman is lactating or when cancer cells form. If the vaccine has correctly trained the immune system, it will destroy cancer cells before they form a tumor.So far, 14 other women have met the criteria for the trial. We were eligible because we'd been treated for TNBC within the past three years and were at high risk of a recurrence. I was the first person to get the vaccine. You get three doses, two weeks apart. I had one in each leg and one in the stomach. The medical staff in the room applauded. We were all so hopeful.<div type="image" title="Jennifer Davis, wearing a head wrap during her treatment for breast cancer, in a selfie with her husband, Brian." height="1737" width="2316" msid="100702749" hostid="261" sizebytes="257062"></div>We've been closely monitored for almost two years now. The results have shown that the immune system is responding as everyone wanted it to. Nobody's cancer has come back. It feels like a miracle.The next phase of the trial will be done on women with the <a href="https://www.insider.com/my-daughter-and-i-have-brca1-gene-mutation-breast-cancer-2022-9">BRCA gene</a> — those who've had prophylactic mastectomies because of their increased chance of developing breast cancer. The last phase will involve a double-blind study of thousands of women across the world.If everything goes to plan, the vaccine could receive approval from the <a href="https://www.insider.com/jeff-bridges-almost-died-covid-chemotherapy-2022-5">Food and Drug Administration</a> within the next five years. Anixa has been focused on TNBC because it's the most lethal type of breast cancer. But they believe the vaccine will also prevent other types of breast cancer.A recurrence of my cancer is no longer a topic of discussion in our family. I have two daughters, and it's incredible to think that within my lifetime and theirs, breast cancer could be a thing of the past.Editor's note: Insider contacted Dr. Amit Kumar, the CEO of Anixa Biosciences. "Looking at the technology, it's a very unique approach to preventing breast cancer," he said. "It's a bold statement to make, but assuming the data continues to look as good as it has, and assuming we do the larger studies, it's possible that we might be able to eliminate virtually all breast cancers." For more information about the trial, visit <a href="https://www.clinicaltrials.gov/ct2/show/NCT04674306" target="_blank" rel="noopener">ClinicalTrials.gov</a>.Do you have a powerful story to share with Insider? Please send details to jridley@insider.com.

I was one the first people to get a vaccine for breast cancer. It could save millions of lives worldwide.

New Delhi, A Delhi-based company, Kanti Commercials is leading a consortium along with <keyword id="10435222" type="COMPANY" weightage="20" keywordseo="fragment-nivesh-and-enormous-nivesh">Fragment Nivesh and Enormous Nivesh</keyword> who put an EoI for Air India. In its expression of interest (EoI) for Air India, Kanti Commercials has said, "We are very much eligible to bid for the disinvestment programme of Air India and have expertise in for turning around <keyword id="10435223" type="UNKNOWN" weightage="20" keywordseo="sick-industrial-enterprises">sick industrial enterprises</keyword> into profitable ones". "For the past many years, we have completed many such acquisitions and achieved great success. We are in touch with a team of professional advisors and specialists who can help us revive sick units into profitable ones", the EoI said. "Moreover, we are bidding as a consortium of 3 members with the help of a <keyword id="6370632" type="UNKNOWN" weightage="20" keywordseo="Special-purpose-vehicle">Special Purpose Vehicle</keyword> (SPV). The lead member is Kanti Commercials and other members are Fragment Nivesh and Enormous Nivesh", Sourav Bag, Director, Kanti Commercials said in the EoI with the relevant documents. <keyword id="10435224" type="COMPANY" weightage="20" keywordseo="kanti-commercials-private-limited">Kanti Commercials Private Limited</keyword> is a Private incorporated on April 1, 2003. It is classified as non-govt company and is registered at Registrar of Companies, Delhi. Its <keyword id="10435221" type="UNKNOWN" weightage="20" keywordseo="authorized-share-capital">authorized share capital</keyword> is ₹1.3 crore and its paid up capital is ₹13.54 lakh. It is involved in other wholesale activity which includes <keyword id="10435225" type="UNKNOWN" weightage="20" keywordseo="specialized-wholesale">specialized wholesale</keyword> not covered in any one of the previous categories and wholesale in a variety of goods without any particular specialization. The directors of Kanti Commercials Private Limited are Sourav Bag and Amit Kumar Joshi. SEE ALSO: <a href="https://www.businessinsider.in/stock-market/news/top-stocks-to-watch-ril-airtel-vodafone-idea-tcs-tata-steel-cams-nmdc-and-others/articleshow/79732131.cms">Top stocks to watch — RIL, Airtel, Vodafone-idea, TCS, Tata Steel, CAMS, NMDC and others</a> <a href="https://www.businessinsider.in/tech/news/comparing-the-apple-m1-macbook-vs-the-intel-macbook/articleshow/79733783.cms">Apple vs Intel – Comparing the Apple M1 MacBook vs the Intel MacBook</a>

Delhi-based Kanti Commercials-led consortium puts in an expression of interest for Air India

<keyword id="6986952" type="COMPANY" weightage="20" keywordseo="IDFC-First-Bank">IDFC First Bank</keyword> has launched <keyword id="9304001" type="UNKNOWN" weightage="20" keywordseo="video-kyc-facility">video KYC facility</keyword> so that customers can open savings accounts without the need to visit a branch office. The zero-contact method completely does away with paper work or biometric verification, thereby removing physical interaction between the bank and customer from the know your customer (<keyword id="167905" type="COMPANY" weightage="20" keywordseo="KYC">KYC</keyword>) process, <keyword id="6361420" type="DOMAIN" weightage="20" keywordseo="IDFC">IDFC</keyword> First Bank said in a release. <div type="Article" hostid="261" msid="75990965" title="How to open a bank savings account using video KYC" mstype="2" mssubtype="0"></div> Customers can start earning 7 per cent interest and maximise their returns on funds held or invested anywhere else, it added. "Video KYC makes the online journey for opening savings accounts simple and fast as customers do not have to venture outside their homes or meet anyone from the bank to complete the process," said Amit Kumar, Head – Retail Liabilities, IDFC First Bank. This is especially relevant in the current times given loss of incomes and low returns offered by most other options, Kumar said. The RBI-sanctioned video-based KYC process for opening of online <keyword id="114757" type="PERSON" weightage="20" keywordseo="Savings-Account">savings account</keyword> allows customers to open a full-fledged savings account with no limit on maximum account balance. The pandemic has altered the way customers want to interact with their banks as they increasingly rely on digital and mobile channels to transact, the lender said. SEE ALSO: <a href="https://www.businessinsider.in/finance/news/sbi-axis-bank-and-kotak-mahindra-bank-and-other-banking-stocks-are-raising-capital-to-fill-npa-hole/articleshow/76054599.cms" data-type="tilCustomLink">Indian lenders like SBI, Axis Bank and others need $20 billion⁠ in capital— most of it will go into filling up NPA holes</a>

After Kotak Mahindra Bank, IDFC First Bank launches video KYC facility for customers to open savings accounts

Chandigarh, Dec 20 () The revenue under State GST has recorded a growth of 33 per cent in November this year, compared to the corresponding month previous year.
The overall growth of the collections under State GST up to November in the current financial year stood at 18 per cent over the same period previous fiscal.
This was informed in a review meeting held via video conferencing of the excise and taxation officials of Haryana under the Chairmanship of Excise and Taxation Commissioner Amit Kumar Agrawal.
It was informed that the return compliance of the state has also shown marked improvement in November 2019. It stands at 78 per cent, which is 4 per cent higher than the national average, according to an official statement here.
Agrawal directed the officials to ensure 100 per cent return compliance by the top taxpayers of the state. At present, the compliance of top taxpayers for the month stands at 93 per cent.
The excise officials have also been directed to conduct physical verification of 3,000 non-filers of returns under GST across the state. This exercise will be completed by December 23, 2020.
The field officers were further directed to ensure that physical verification of each new taxpayer be conducted within 15 days of registration.
Agarwal directed all district heads to strictly adhere to the timelines fixed for the issuance of refunds. Any pendency of refunds is to be removed within seven days, he added. SUN BAL

You Searched For "Amit Kumar" and got 4 results

I was one the first people to get a vaccine for breast cancer. It could save millions of lives worldwide.

Jane Ridley

Delhi-based Kanti Commercials-led consortium puts in an expression of interest for Air India

IANS

After Kotak Mahindra Bank, IDFC First Bank launches video KYC facility for customers to open savings accounts

PTI

Haryana's revenue under State GST records 33 pc growth in Nov

PTI

Popular Keywords

Buying Guides